Your browser doesn't support javascript.
loading
Dubious effects of methadone as an "anticancer" drug on ovarian cancer cell-lines and patient-derived tumor-spheroids.
Fiegl, Heidelinde; Hagenbuchner, Judith; Kyvelidou, Christiana; Seeber, Beata; Sopper, Sieghart; Tsibulak, Irina; Wieser, Verena; Reiser, Elisabeth; Roessler, Julia; Huhtinen, Kaisa; Carpén, Olli; Parson, Walther; Sprung, Susanne; Marth, Christian; Ausserlechner, Michael J; Zeimet, Alain G.
Afiliación
  • Fiegl H; Department of Obstetrics and Gynecology, Medical University of Innsbruck, Innsbruck, Austria.
  • Hagenbuchner J; Department of Pediatrics II, Medical University Innsbruck, Innsbruck, Austria.
  • Kyvelidou C; Department of Gynecological Endocrinology and Reproductive Medicine, Medical University of Innsbruck, Innsbruck, Austria.
  • Seeber B; Department of Gynecological Endocrinology and Reproductive Medicine, Medical University of Innsbruck, Innsbruck, Austria.
  • Sopper S; Internal Medicine V, Medical University of Innsbruck, Innsbruck, Austria; Tyrolean Cancer Research Institute, Innsbruck, Austria.
  • Tsibulak I; Department of Obstetrics and Gynecology, Medical University of Innsbruck, Innsbruck, Austria.
  • Wieser V; Department of Obstetrics and Gynecology, Medical University of Innsbruck, Innsbruck, Austria.
  • Reiser E; Department of Obstetrics and Gynecology, Medical University of Innsbruck, Innsbruck, Austria.
  • Roessler J; Department of Obstetrics and Gynecology, Medical University of Innsbruck, Innsbruck, Austria.
  • Huhtinen K; Cancer Research Program, Institute of Biomedicine and FICAN West Cancer Centre, University of Turku, Turku, Finland.
  • Carpén O; Cancer Research Program, Institute of Biomedicine and FICAN West Cancer Centre, University of Turku, Turku, Finland; Research Programs Unit, Genome-Scale Biology and Medicum, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
  • Parson W; Institute of Legal Medicine, Medical University of Innsbruck, Innsbruck, Austria; Forensic Science Program, The Pennsylvania State University, University Park, PA, USA.
  • Sprung S; Department of Pathology, Neuropathology and Molecular Pathology, Medical University of Innsbruck, Innsbruck, Austria.
  • Marth C; Department of Obstetrics and Gynecology, Medical University of Innsbruck, Innsbruck, Austria.
  • Ausserlechner MJ; Department of Pediatrics I, Medical University Innsbruck, Innsbruck, Austria. Electronic address: Michael.J.Ausserlechner@i-med.ac.at.
  • Zeimet AG; Department of Obstetrics and Gynecology, Medical University of Innsbruck, Innsbruck, Austria. Electronic address: Alain.Zeimet@i-med.ac.at.
Gynecol Oncol ; 165(1): 129-136, 2022 04.
Article en En | MEDLINE | ID: mdl-35033381
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Antineoplásicos Tipo de estudio: Prognostic_studies Límite: Female / Humans Idioma: En Revista: Gynecol Oncol Año: 2022 Tipo del documento: Article País de afiliación: Austria
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Antineoplásicos Tipo de estudio: Prognostic_studies Límite: Female / Humans Idioma: En Revista: Gynecol Oncol Año: 2022 Tipo del documento: Article País de afiliación: Austria